Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders

NCT04218981 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT04218981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04218981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
Lead sponsor
Central South University
Phase
Not applicable
Overall status
Completed
Start date
January 15, 2020
Completion date
December 31, 2023
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common mental disorder